Nora Khiar-Fernández

Chemistry for the Identification of Therapeutic Targets: Recent Advances and Future Directions

S. Ortega‐Gutiérrez, B. Marcos‐Ramiro, Nora Khiar-Fernández, 2021 .

Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA2), UCM-14216, Ameliorates Spinal Cord Injury in Mice

Manisha Ray, M. López-Rodríguez, S. Ortega‐Gutiérrez, 2022, Journal of medicinal chemistry.

A novel agonist of the type 1 lysophosphatidic acid receptor (LPA1), UCM-05194, shows efficacy in neuropathic pain amelioration.

J. Chun, A. Ferrer-Montiel, R. Rivera, 2019, Journal of medicinal chemistry.

Isoprenylcysteine Carboxylmethyltransferase-Based Therapy for Hutchinson–Gilford Progeria Syndrome

S. Nourshargh, V. Andrés, M. López-Rodríguez, 2021, ACS central science.